Euro Pharmacists Slam On-Line Drug Sales

23 June 1996

The annual conference of Pharmacists of the European Union, the ZAEU, has rejected the idea of drug delivery by mail order, either by ordering on the Internet or through forms of tele-shopping.

Johannes Pieck, spokesman for the executive of the German pharmacists' federation, told the meeting that such a form of selling would exclude the provision of information and advice by pharmacists.

This view was shared by the participants from 18 European countries and, said Dr Pieck, by the German Health Ministry. However, in the European Union as a whole there is no regulatory framework covering the ways in which drugs are sold, because the European Commission has left decisions on a ban on drug delivery by tele-shopping to individual countries. Dr Pieck said this was unsatisfactory in a single market.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight